Cannabidiol, or CBD, has emerged from cannabis’s shadow as a distinct therapeutic compound worthy of serious medical consideration. Unlike its psychoactive counterpart THC, CBD interacts with the body’s endocannabinoid system without producing intoxication, making it an attractive option for patients seeking relief without altered consciousness.
Current research supports CBD’s effectiveness for several specific conditions. The FDA has approved Epidiolex, a CBD-based medication, for treating severe epilepsy syndromes including Dravet syndrome and Lennox-Gastaut syndrome, where clinical trials demonstrated …
Therapeutic CBD: What Science Says About Real Relief and Recovery






